Faizan Farooque

Faizan Farooque

Expertise: Real estate investment trusts (REITs), SPACs, Cryptocurrencies

Education: BSc (Hons) Degree in Applied Accounting, Oxford Brookes University; Introduction to Data Analysis Using Excel, Rice University; Excel Skills for Business: Intermediate, Macquarie University

About Faizan
Faizan Farooque is a finance journalist who has reported on the latest trends in the stock market for many years. He helps people by providing advice about saving and investing and keeping up with what’s happening in the financial world.

Faizan is writing for InvestorPlace.com, GuruFocus, and TipRanks and has previously worked as a financial journalist and data analyst for S&P Global. He can analyze company filings from sources like SEC, FINRA, and others to help identify potential investment opportunities. Researching specific industries is also something he does to provide industry insight for clients.

Faizan deeply understands the market and how to read the financial tea leaves to anticipate where things are headed. His expertise gives readers an insider’s perspective on what’s happening in the finance world so they can make smart decisions.

Recent Articles

Not the Right Time to Purchase Shiba Inu After Musk Strikes Again

Shiba Inu is doing very well along with other meme coins, but without more use cases things, prospects are looking grim for this one.

With Government Shutdown Averted, the Time Is Right to Buy Ethereum

Ethereum is soaring and although there will be some profit-taking in between, the trajectory is onwards and upwards before the next upgrade.

7 Short Squeeze Stocks to Buy That Could Be the Next GameStop

Short squeeze stocks are becoming popular by the day. The reason is Redditors and their insatiable desire to punish the big hedge funds.

7 Value Stocks to Buy Trading at an Astounding Discount

Over the long term, value stocks have been one of the best investments there is, which is why you need to keep these seven companies in mind.

Novavax Stock Looks Interesting as the World Still Needs Vaccines

There are plenty of reasons to stay invested in NVAX stock as the Delta variant forces a renewal of fortunes for the vaccine also-ran.